Search

Search Constraints

You searched for: Author/Creator Dayen, Charles

Search Results

2. Weekly paclitaxel plus bevacizumab versus docetaxel as second- or third-line treatment in advanced non-squamous non–small-cell lung cancer: Results of the IFCT-1103 ULTIMATE study. (May 2020)